Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-25 @ 4:53 PM
Study NCT ID:
NCT04794803
Status:
TERMINATED
Last Update Posted:
2024-01-08
First Post:
2021-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Reparixin in COVID-19 Pneumonia - Efficacy and Safety
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-08
First Submit QC Date:
None
Study First Post Date:
2021-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-02-21
Results First Submit QC Date:
None
Results First Post Date:
2022-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-05
Last Update Post Date:
2024-01-08
Last Update Post Date Type:
ACTUAL